Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
PRPO 
Precipio Inc (PRPO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/12/2025: PRPO (3-star) is a STRONG-BUY. BUY since 18 days. Simulated Profits (6.80%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $19
1 Year Target Price $19
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 55.81% | Avg. Invested days 34 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 12/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 31.61M USD | Price to earnings Ratio - | 1Y Target Price 19 |
Price to earnings Ratio - | 1Y Target Price 19 | ||
Volume (30-day avg) 1 | Beta 1.11 | 52 Weeks Range 3.90 - 28.50 | Updated Date 11/14/2025 |
52 Weeks Range 3.90 - 28.50 | Updated Date 11/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.19 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.48% | Operating Margin (TTM) -14.57% |
Management Effectiveness
Return on Assets (TTM) -9.05% | Return on Equity (TTM) -14.76% |
Valuation
Trailing PE - | Forward PE 15.43 | Enterprise Value 45004614 | Price to Sales(TTM) 1.92 |
Enterprise Value 45004614 | Price to Sales(TTM) 1.92 | ||
Enterprise Value to Revenue 1.97 | Enterprise Value to EBITDA 91.85 | Shares Outstanding 1619584 | Shares Floating 1293837 |
Shares Outstanding 1619584 | Shares Floating 1293837 | ||
Percent Insiders 12.97 | Percent Institutions 14.77 |
About Precipio Inc
Exchange NASDAQ | Headquaters New Haven, CT, United States | ||
IPO Launch date 2000-07-18 | Founder, President, CEO & Director Mr. Ilan Danieli | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 54 | Website https://www.precipiodx.com |
Full time employees 54 | Website https://www.precipiodx.com | ||
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.